[go: up one dir, main page]

WO2008105540A1 - Pharmaceutical agent and food effective on allergic disease and autoimmune disease - Google Patents

Pharmaceutical agent and food effective on allergic disease and autoimmune disease Download PDF

Info

Publication number
WO2008105540A1
WO2008105540A1 PCT/JP2008/053681 JP2008053681W WO2008105540A1 WO 2008105540 A1 WO2008105540 A1 WO 2008105540A1 JP 2008053681 W JP2008053681 W JP 2008053681W WO 2008105540 A1 WO2008105540 A1 WO 2008105540A1
Authority
WO
WIPO (PCT)
Prior art keywords
disease
pharmaceutical agent
lactic acid
seed
acid bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/053681
Other languages
French (fr)
Japanese (ja)
Inventor
Takanari Tominaga
Yoshio Kumazawa
Kiichiro Kawaguchi
Takao Mukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TK BIO-RESEARCH LABORATORY Co Ltd
Original Assignee
TK BIO-RESEARCH LABORATORY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TK BIO-RESEARCH LABORATORY Co Ltd filed Critical TK BIO-RESEARCH LABORATORY Co Ltd
Priority to JP2009501325A priority Critical patent/JP4990352B2/en
Publication of WO2008105540A1 publication Critical patent/WO2008105540A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)

Abstract

Disclosed are a pharmaceutical agent and a food which can treat, ameliorate or prevent an allergic disease such as type I allergic disease and an autoimmune disease such as rheumatoid arthritis and inflammatory bowel disease effectively and safely. Specifically disclosed are: a pharmaceutical agent comprising a lactic acid bacterium fermentation product of a grape skin/seed which is produced by fermenting at least one of a grape skin and a grape seed with a lactic acid bacterium; and a food comprising a lactic acid bacterium fermentation product of a grape skin/seed which is produced by fermenting at least one of a grape skin and a grape seed with a lactic acid bacterium.
PCT/JP2008/053681 2007-03-01 2008-02-29 Pharmaceutical agent and food effective on allergic disease and autoimmune disease Ceased WO2008105540A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009501325A JP4990352B2 (en) 2007-03-01 2008-02-29 Drugs effective for allergic diseases and autoimmune diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007051662 2007-03-01
JP2007-051662 2007-03-01

Publications (1)

Publication Number Publication Date
WO2008105540A1 true WO2008105540A1 (en) 2008-09-04

Family

ID=39721362

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053681 Ceased WO2008105540A1 (en) 2007-03-01 2008-02-29 Pharmaceutical agent and food effective on allergic disease and autoimmune disease

Country Status (2)

Country Link
JP (1) JP4990352B2 (en)
WO (1) WO2008105540A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010279286A (en) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd Fermented grape and method for producing the same
JP2010280602A (en) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd Antiallergic composition
JP2011010648A (en) * 2009-06-04 2011-01-20 Nippon Bio Co Ltd Metabolic syndrome-improving composition
JP2012020974A (en) * 2010-07-15 2012-02-02 Yasutomo Arashima Lactobacillus-cocultivated extract
WO2012172631A1 (en) * 2011-06-13 2012-12-20 Yoshino Masaru Fermented food paste
US9504720B2 (en) 2011-02-02 2016-11-29 Asahi Group Holdings, Ltd. Substance for preventing and improving arthritis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001346537A (en) * 2000-06-07 2001-12-18 Sansei Shokuhin Kk Functional food using fruit rind and method for producing the same
JP2004187672A (en) * 2002-11-29 2004-07-08 Toyo Shinyaku:Kk Method for producing fermented product containing pericarp of fruit
JP2005053862A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Prophylactic/therapeutic agent for inflammatory disease
JP2007031326A (en) * 2005-07-26 2007-02-08 Akita Prefecture Production method for increasing aldose reductase inhibiting activity by alcoholic fermentation and aldose reductase inhibiting agent in fruit wine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4726022B2 (en) * 2000-03-28 2011-07-20 キッコーマン株式会社 Antiallergic and anti-inflammatory agents and pharmaceutical compositions, quasi-drugs, cosmetics, foods and animal feeds containing the same
ITMI20020756A1 (en) * 2002-04-09 2003-10-09 Sinclair Pharma S R L TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DERMATITIS
JP2006096694A (en) * 2004-09-29 2006-04-13 Asahi Breweries Ltd Food allergy prevention agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001346537A (en) * 2000-06-07 2001-12-18 Sansei Shokuhin Kk Functional food using fruit rind and method for producing the same
JP2004187672A (en) * 2002-11-29 2004-07-08 Toyo Shinyaku:Kk Method for producing fermented product containing pericarp of fruit
JP2005053862A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Prophylactic/therapeutic agent for inflammatory disease
JP2007031326A (en) * 2005-07-26 2007-02-08 Akita Prefecture Production method for increasing aldose reductase inhibiting activity by alcoholic fermentation and aldose reductase inhibiting agent in fruit wine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YUNOKI K.: "Aka Wine no Alcohol Hakko to Nyusan Hakko Katei deno Resveratrol Kanren Busshitsuryo no Henka", JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY, vol. 51, no. 5, 2004, pages 274 - 278 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010279286A (en) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd Fermented grape and method for producing the same
JP2010280602A (en) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd Antiallergic composition
JP2011010648A (en) * 2009-06-04 2011-01-20 Nippon Bio Co Ltd Metabolic syndrome-improving composition
JP2012020974A (en) * 2010-07-15 2012-02-02 Yasutomo Arashima Lactobacillus-cocultivated extract
US9504720B2 (en) 2011-02-02 2016-11-29 Asahi Group Holdings, Ltd. Substance for preventing and improving arthritis
WO2012172631A1 (en) * 2011-06-13 2012-12-20 Yoshino Masaru Fermented food paste

Also Published As

Publication number Publication date
JPWO2008105540A1 (en) 2010-06-03
JP4990352B2 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
WO2008093670A1 (en) Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same
Zhang et al. Changes in intestinal microbiota of type 2 diabetes in mice in response to dietary supplementation with instant tea or matcha
Terpend et al. Arabinogalactan and fructo‐oligosaccharides have a different fermentation profile in the S imulator of the H uman I ntestinal M icrobial E cosystem (SHIME®)
WO2008105540A1 (en) Pharmaceutical agent and food effective on allergic disease and autoimmune disease
WO2010007332A3 (en) Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being
WO2012060579A3 (en) Dead lactobacillus biomass for antimicrobial use and a production method therefor
WO2011103123A3 (en) Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
WO2009103884A3 (en) Composition for human and/or animal nutrition, uses thereof and yeasts
BRPI0515618A (en) lactobacillus plantarum strain, composition to produce cla, process for mass production of cla functional body fat reducing food, daily products, fermented foods, medicine for prevention and treatment of obesity related diseases
NZ596788A (en) Use of selected lactic acid bacteria for reducing infantile colic
WO2012012467A3 (en) Modulation of nuclear-retained rna
WO2008088008A1 (en) Prophylactic and/or therapeutic agent for functional dyspepsia
WO2007136762A3 (en) Production of fatty acids and derivatives thereof
WO2009045370A3 (en) Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
SI1931363T1 (en) Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
MX345063B (en) Probiotic strains for use in improving the enteric nervous system.
WO2008041966A3 (en) Broad spectrum antibacterial compounds
RU2018119309A (en) FAECALIBACTERIUM PRAUSNITZII AND DESULFOVIBRIO PIGER FOR USE WHEN TREATING OR PREVENTING DIABETES AND INTESTINAL DISEASES
Palomino et al. Application of Lactobacillus plantarum Lb9 as starter culture in caper berry fermentation
EP1949792A3 (en) The healthy and functional foods for the obesity patients using purple-colored potato
EP2727994A4 (en) NOVEL LACTIC ACID BACTERIUM AND PROCESS FOR THE PREPARATION OF SILAGE OR FERMENTED FOOD PRODUCTS USING THE SAME
BRPI0515227A (en) lactobacillus rhamnosus strain, cla production composition, cla mass production process, body fat-reducing functional food, daily products, fermented foods and obesity-related disease prevention and treatment medicine
WO2010111344A3 (en) Methods and microorganisms for production of c4-dicarboxylic acids
PL401887A1 (en) Method for producing a fermentation product containing hydrolyzate sugar
WO2009047881A1 (en) Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08721101

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009501325

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08721101

Country of ref document: EP

Kind code of ref document: A1